IP Verse

A Liquid Formulation Of Long-Acting Insulin And Insulinotropic Peptide - EP2877201

The patent EP2877201 was granted to Hanmi Pharm on Jun 5, 2019. The application was originally filed on Jul 25, 2013 under application number EP13822545A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2877201

HANMI PHARM
Application Number
EP13822545A
Filing Date
Jul 25, 2013
Status
Granted And Under Opposition
May 3, 2019
Grant Date
Jun 5, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

JAMES POOLEMar 5, 2020MARSHALLWITHDRAWN

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONKR100725315B
DESCRIPTIONKR101058290B
DESCRIPTIONKR20110134210
DESCRIPTIONUS5424286
INTERNATIONAL-SEARCH-REPORTKR20110111267
INTERNATIONAL-SEARCH-REPORTKR20120135123
INTERNATIONAL-SEARCH-REPORTWO2011058082
INTERNATIONAL-SEARCH-REPORTWO2011144673
SEARCHUS2009238838

Non-Patent Literature (NPL) Citations (3) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
INTERNATIONAL-SEARCH-REPORT- STROHL, "Optimization of Fc-mediated effector functions of monoclonal antibodies", CURRENT OPINION IN BIOTECHNOLOGY, (2009), vol. 20, no. 6, pages 685 - 691, XP026778879
INTERNATIONAL-SEARCH-REPORT- WANG ET AL., "Novel GLP-1 fusion chimera as potent long acting GLP-1 receptor agonist", PLOS ONE, (2010), vol. 5, pages 1 - 9, XP003028384
SEARCH- KUMAR M ET AL, "Gene therapy of diabetes using a novel GLP-1/IgG1-Fc fusion construct normalizes glucose levels in db/db mice", GENE THERAPY, NATURE PUBLISHING GROUP, GB, vol. 14, no. 2, ISSN 0969-7128, (20070101), pages 162 - 172, (20060831), XP002499114 [Y] 1-30 * abstract * * page 163, column 3 * * page 165, columns 3-5 * * page 167, column 1 *-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents